Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Industry Leaders Back 908 Devices
by Marc S. Reisch
July 6, 2015
| A version of this story appeared in
Volume 93, Issue 27
908 Devices, a Boston-based maker of handheld mass spectrometers, has now raised a total of $29 million from investors, many with long-standing ties to the instrumentation and diagnostics industries. New investors include Paul Meister, former chairman of Thermo Fisher Scientific, and Martin Madaus, CEO of Ortho Clinical Diagnostics. Life sciences investor Casdin Capital also participated. Other industry leaders who have invested in 908 Devices include one-time PerkinElmer executive and current Quanterix CEO Kevin Hrusovsky, Quanterix and Illumina founder David Walt, and Illumina CEO Jay Flatley.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter